Your session is about to expire
← Back to Search
Petrolatum with Non-Stick Gauze for Hidradenitis Suppurativa
N/A
Waitlist Available
Led By Franklin R Blum, BS
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected at 1, 2, 4 and 6 weeks post-surgery
Awards & highlights
No Placebo-Only Group
Summary
This trial compares two types of wound dressings for patients with a severe skin condition called Hidradenitis suppurativa. It aims to find out if petrolatum with non-stick bandaging is better than the traditional wet-to-dry method in terms of healing and comfort. The study will track healing progress and quality of life to determine the best approach.
Eligible Conditions
- Hidradenitis Suppurativa
- Surgical Wound
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ administered at 1, 2, 4 and 6 weeks post-surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~administered at 1, 2, 4 and 6 weeks post-surgery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
PUSH Score Over Time
Pain With Dressing Changes Over Time
Wound QOL Survey Score Over Time
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Petrolatum with Non-Stick GauzeExperimental Treatment1 Intervention
Participants in this arm will receive petrolatum with non-stick gauze.
Group II: Wet-to-dry DressingsActive Control1 Intervention
Participants in this arm will receive standard of care wet-to-dry dressings.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Petrolatum with Non-Stick Gauze
2022
N/A
~80
Find a Location
Who is running the clinical trial?
University of North Carolina, Chapel HillLead Sponsor
1,555 Previous Clinical Trials
4,298,459 Total Patients Enrolled
2 Trials studying Hidradenitis Suppurativa
47 Patients Enrolled for Hidradenitis Suppurativa
Christopher J Sayed, MDStudy DirectorUniversity of North Carolina, Chapel Hill
1 Previous Clinical Trials
32 Total Patients Enrolled
1 Trials studying Hidradenitis Suppurativa
32 Patients Enrolled for Hidradenitis Suppurativa
Franklin R Blum, BSPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You cannot participate if you have a preference for a specific type of bandage.You have had trouble using wet-to-dry or petrolatum and non-stick bandages before.You have undergone a standard-of-care surgical procedure for HS with planned secondary intention healing of the wound.
Research Study Groups:
This trial has the following groups:- Group 1: Petrolatum with Non-Stick Gauze
- Group 2: Wet-to-dry Dressings
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Hidradenitis Suppurativa Patient Testimony for trial: Trial Name: NCT05194969 — N/A
Share this study with friends
Copy Link
Messenger